Darolutamide may offer greater benefits than enzalutamide or apalutamide for Black and White patients with non-metastatic ...
MyCareGorithm was met with high approval from patients, companions, and physicians, with all 3 groups reporting they’d ...
The primary study objective was to evaluate the prognostic value of post-therapeutic SPECT by RECIP 1.0 for overall survival.
(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Keynote Presentation. Dr. William Dahut discussed how ...
Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...
Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...
A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...
Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...
Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...
HBC achieved full-year sales revenue of NOK 256.8 million, a 35% increase from 2023, with strong momentum in higher-margin B2B human nutrition. The shift towards premium products, particularly CalGo® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback